HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Topical Antimicrobial Proposed Rule Slated For March in “Unified Agenda”

This article was originally published in The Tan Sheet

Executive Summary

A proposed rule on consumer topical antimicrobial products is scheduled for March 2006 release, according to HHS' semi-annual "unified agenda" published in the Federal Register Oct. 31

You may also be interested in...



New NSF Certification Program Tests For Extensive List Of Banned Substances

NSF International is launching a new third-party certification program that will test dietary supplements for an all-inclusive list of banned athletic substances

Supplement GMPs Received By OMB For 90-Day Clearance Review

FDA's goal of issuing a final rule on dietary supplement current Good Manufacturing Practices by the end of the year may be within reach

NSAID Labeling Revisions Revised By FDA; Compliance Date Extended

FDA has deleted the part of its recommended heart risk warning for NSAIDs that discourages use for "longer than 10 days or more than the recommended dose.

Related Content

Topics

UsernamePublicRestriction

Register

RS126704

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel